Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
AKR1C3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IFNL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PAPSS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C5orf56 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFSF10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GMPR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCL2L14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RTP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BATF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRANK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GIMAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on